SURGING TODAY Drug Manufacturers - Specialty & Generic $1.79B Cap Quant: HOLD

Why Is Harrow, Inc. (HROW) Stock Up Today?

Updated Nov 17, 2026 6:30 PM ET · Prev Close $29.09

Pro Workspace
Last Session Price
$29.51 +1.44%
+$0.42 vs $29.09 prior close
Intraday Range
$28.75 – $29.74
Open $29.00
Relative Volume
0.26x Avg
203,668 sh
52-Week Range
$25.76 – $54.85
Benchmark Alpha
+2.35% vs SPY
+2.23% vs QQQ
20-Session Trend +4.5%

Primary Move Catalyst & Conviction

67% Signal Conviction
OPTIONS 75% Driver Weight

Unusual Call buying detected

Options traders are heavily buying calls on HROW, with 96% of volume in calls. This suggests bullish institutional positioning.

SYMPATHY 60% Weight
Outperforming sector by 4.0%

This stock is significantly outperforming its Pharmaceuticals & Therapeutics sector peers, suggesting a stock-specific catalyst.

Volume Confirmation
LOW VOLUME (0.26x) Unconfirmed
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 67%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

HROW outperforming the S&P 500 by +2.35%
HROW Session
+1.44%
$29.51
S&P 500 (SPY)
-0.91%
$733.21
Nasdaq 100 (QQQ)
-0.79%
$656.55
Healthcare (XLV)
-0.94%
$186.12
Alpha vs SPY: +2.35% Alpha vs QQQ: +2.23% Alpha vs XLV: +2.38%
Peer Group: Pharmaceuticals & Therapeutics (-1.9% avg) Outperforming peers by +4.1%

Options Flow & Execution Desk

Bullish Flow · P/C 0.08
Call Volume
18,814
Contracts
Put Volume
1,537
Contracts
Put / Call Ratio
0.08
20,351 total vol
Implied Volatility
103.5%
Chain avg IV

Unlock 1 Unusual HROW Options Sweep Strike

See exact institutional strike concentrations, volume-to-OI ratios, and multi-leg payoff blueprints with Tradestie Pro.

Recent HROW Catalyst Headlines

Verified Wire
Harrow to Participate in Two Investor Conferences in November

Nashville, Tenn., Nov. 12, 2026 Globe Newswire -- Harrow Nasdaq HROW , a leading provider of ophthalmic disease management solutions in North America, today announced that management will participate in the following inv

Yahoo Finance · Nov 12, 2026

1–3 Day Expected Range & Key Level

45% Follow-Through
Lower Bound
$29.13
Short-term support band
Upper Bound
$30.61
Short-term resistance band
Key Inflection Level
$31.21 (resistance)

Watch for continuation above $29.72

Technical Regime (HROW)

MIXED MA TREND
RSI (14)
51.8
Bullish
20-Day SMA
$28.67
Above 20d
50-Day SMA
$30.42
Below 50d
MACD Signal
Bullish
MACD -0.31
ADX (14)
33.9
Strong trend
10d Momentum
+1.18
Positive 10-day momentum

1-Year Historical Move Analogs

39 Events

Sessions in the past year where HROW moved >3.0% up:

Continuation Rate
61.5%
24/39 sessions
Avg Next-Day Move
+0.16%
T+1 session return
Last analog: Nov 13, 2026 (+6.4%) → Next session: -3.4%

Retail & Crowd Sentiment

Very Bullish
24h Messages
1
7d avg 2.4
Bullish / Bearish
100.0% / 0.0%
Low buzz
Crowd Discussion Digest

User on StockTwits reported that Opaleye, a significant shareholder in $HROW, sold more shares during Q3.

Reddit communities: 1 comment (Bearish)

About Harrow, Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and no...

Sector
Healthcare
Market Cap
$1.79B
Forward P/E
18.3x
Employees
382

Get Instant HROW Catalyst Alerts

Receive an email alert when HROW triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

HROW Session & Catalyst FAQ

Why is HROW stock up today?

Options traders are heavily buying calls on HROW, with 96% of volume in calls. This suggests bullish institutional positioning.

Is HROW stock a buy or sell right now?

Today's session carries a 67% catalyst conviction score on 0.26x relative volume (low participation). Our multi-factor model currently rates HROW as HOLD. Review full valuation, quality, and timing signals on the HROW Buy or Sell Decision Brief →

What is HROW's intrinsic value and expected trading range?

At $29.51, HROW's modeled 1-to-3 session range is $29.13 – $30.61, with a key inflection level at $31.21 (resistance). Compare current price against multi-year cash flow projections in the HROW Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for HROW?

RSI at 51.8 reflects constructive bullish momentum. HROW trades at $29.51 relative to its 20-day SMA ($28.67) and 50-day SMA ($30.42), reflecting a mixed moving-average structure.

Tradestie Flagship Research & Market Hubs